Smart Meter Webinar: Tonight 6 pm ET
Smart Meter Webinar:
Tonight 6 pm ET
|
_______________
**Comment**
Apologies for the tardiness of this. Just found it but wanted to share.
|
_______________
**Comment**
Apologies for the tardiness of this. Just found it but wanted to share.
https://www.lymedisease.org/navigating-disability-insurance/

By Edward Dabdoub
10/22/25
Lyme disease can cause serious and lasting impairments that make it impossible to work full-time.
Yet, because symptoms of Lyme disease are typically subjective, or self-reported, insurance companies tend to question the legitimacy of Lyme-related claims.
Oftentimes, disability insurance companies will deny long term disability (LTD) claims because there is no standard testing to prove impairment caused by ongoing symptoms.
If you are unable to work due to the ongoing impact of Lyme disease and your doctors agree you should stop working, you may be eligible for LTD insurance benefits.
Disability insurance coverage provided by an employer is usually governed by a federal law called ERISA. This law has specific requirements for submitting a short-term and long-term claim and appealing a denied claim.
It is important to obtain a copy of the short-term and long-term disability insurance policies from your employer to understand what is necessary for the claim or appeal and by when it is due. Deadlines are very strict in ERISA disability claims. A missed deadline could prevent you from pursuing the claim further.
Common symptoms and complications of Lyme disease that prevent people from working may include:
When symptoms last for an extended period, they can interfere with your ability to perform your job duties consistently. It is at that point you may need to look into your disability insurance coverage through work or even individually (if you took out a disability insurance policy previously).
Insurance companies are notoriously skeptical of Lyme disease disability claims, especially if:
One of the most important aspects of a disability insurance claim, especially for a condition like Lyme disease, is to ensure you are being treated regularly by doctors, and that your doctors are supportive of your disability.
You will need their support when completing paperwork and throughout the duration of your LTD claim and benefit payments. It is important they also maintain detailed medical records of your ongoing symptoms, their observations of pain or fatigue or brain fog, and any abnormal exam findings.
Disability insurance companies will scrutinize your medical records looking for inconsistencies or lack of detail as to how your symptoms impact your functionality. Some commons bases for long term disability claim denials include:
Getting approved for LTD benefits for Lyme disease requires strong, consistent medical and non-medical evidence that corroborates your reported symptoms and bolsters your credibility. The following is a brief list of things you may want to gather as part of your LTD claim or appeal:
Fighting for long term disability insurance benefits due to Lyme disease can be frustrating, but there is hope. With strong support from your treating providers, detailed medical records, and evidence demonstrating your restrictions and limitations, disability insurance companies have approved these claims. If you have questions or concerns about your claim, you should reach out to a disability insurance attorney who can guide you on how best to handle your claim.
Edward Dabdoub is the founder and managing partner of the Dabdoub Law Firm, a national practice that specializes in long-term disability insurance claims.
For more:

Follow-up email to Adrian Duncan, Group Vice President, Global Head of Education & Medical Affairs at WebMD.
First email can be found here.
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “aduncan@webmd.net” <aduncan@webmd.net>
Cc: “cme@medscape.net” <cme@medscape.net>, “caitlin@medlitera.com” <caitlin@medlitera.com>, “naseem@medlitera.com” <naseem@medlitera.com>, “michelle@medlitera.com” <michelle@medlitera.com>
Date: 10/28/2025 9:28 AM EDT
Subject: Re: Medscape Now! Understanding the Latest Evidence and Best Practices for Interprofessional Care of Post-Treatment Lyme Disease Syndrome
Dear Mr. Duncan,
In 2016 Dr. Paul Auwaerter, past president of the Infectious Diseases Society of America coauthored a study revealing the persister form of Borrelia burgdorferi resistant to antibiotics.
Here is a timeline of events:
2015
Standard antibiotic treatment for Lyme disease does not kill persistent Borrelia bacteria.
http://droopyyoupi.blogspot.com/2015/08/standart-antibiotic-treatment-for-lyme.html
Excerpt:
–What has tuberculosis and Borrelia burgdorferi in common? In the late stage of the disease occurs persistent (tolerant) bacteria, which essentially means that the bacteria lasts and lasts and lasts. They protect themselves against antibiotics and are difficult to treat.
–Both Borrelia burgdorferi and tuberculosis is relatively easy to cure in the early stages, even with the use of one antibiotic. In the late stage it is impossible to cure the disease with the same type of treatment in the acute phase, said Dr. Ying Zhang when he visited the year NorVect conference.
-Dr. Ying Zhang is a professor at the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health
–Two days after NorVect conference, published Dr. Ying Zhang’s latest research Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
2016
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library
Jie Feng 1, Wanliang Shi 1, Shuo Zhang 1, David Sullivan 1, Paul G Auwaerter 2, Ying Zhang 1
https://pubmed.ncbi.nlm.nih.gov/27242757/
Abstract
Under experimental stress conditions such as starvation or antibiotic exposure, Borrelia burgdorferi can develop round body forms, which are a type of persister bacteria that appear resistant in vitro to customary first-line antibiotics for Lyme disease. To identify more effective drugs with activity against the round body form of B. burgdorferi, we established a round body persister model induced by exposure to amoxicillin (50 μg/ml) and then screened the Food and Drug Administration drug library consisting of 1581 drug compounds and also 22 drug combinations using the SYBR Green I/propidium iodide viability assay. We identified 23 drug candidates that have higher activity against the round bodies of B. burgdorferi than either amoxicillin or doxycycline.
2022
Nitroxoline Drug Combinations Are More Active Than Lyme Antibiotic Combination and Can Eradicate Stationary-Phase Borrelia burgdorferi
Alvarez-Manzo, Hector S.1; Zhang, Yumin1; Zhang, Ying2,✉
https://journals.lww.com/imd/fulltext/2022/09000/nitroxoline_drug_combinations_are_more_active_than.7.aspx
Abstract
Lyme disease (LD), caused by Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. Despite the standard 2–4 weeks’ antibiotic treatment, approximately 10%–20% of patients will develop post treatment LD syndrome, a condition that is poorly understood. One of the probable causes is thought to be the presence of B. burgdorferi persister forms that are not effectively killed by the current LD antibiotics. In this study, we evaluated nitroxoline, an antibiotic used to treat urinary tract infections, for its activity against a stationary-phase culture enriched with persister forms of B. burgdorferi. Nitroxoline was found to be more active than doxycycline and equally active as cefuroxime (standard LD antibiotics) against B. burgdorferi. Importantly, the nitroxoline two-drug combinations nitroxoline + cefuroxime and nitroxoline + clarithromycin, as well as the nitroxoline three-drug combination nitroxoline + cefuroxime + clarithromycin, were as effective as the persister drug daptomycin-based positive control three-drug combination cefuroxime + doxycycline + daptomycin, completely eradicating stationary-phase B. burgdorferi in the drug-exposure experiments and preventing regrowth in the subculture study. Future studies should evaluate these promising drug combinations in a persistent LD mouse model.
Mr. Duncan…. This is the missing research that should have been conducted early in the discovery phase of the disease but as we now know, all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. What has been deceitfully established here in the US is wreaking havoc globally. Example: Lyme disease: Australians ‘being treated worse than a dog riddled with mange’, Senator John Madigan says
https://www.abc.net.au/news/2016-01-11/lyme-disease-treatment-in-australia-criticised-by-john-madigan/7080708
This research is being suppressed as the disabled Lyme patient population around the globe remain sick indefinitely. (Three decades and counting)
Carl Tuttle
______________
**Comment**
We should all be eternally grateful for Lyme patient and advocate Carl Tuttle who is like a dog with a bone when it comes to relentlessly fighting for patients. His letter makes numerous salient points completely ignored by the medical machine which runs on ‘consensus’ based medicine auto-pilot, where doctors are nothing more than automatons and where AI is more likely to diagnose patients than doctors.
In part one he calls on patients to write letters to Adrian Duncan of Medscape/WebMD. The medical machine needs to hear from people who live this experience. For ideas, feel free to read the letter I wrote back in 2020 to the TBDWG which I adapted for the Medscape letter. Use your own experience and ask him to retract this harmful CME course for doctors which only entrenches the false narrative of Lyme/MSIDS.
Oct. 26, 2025
**Comment**
Thankfully, there is a global awakening to the tyranny we are living through.
Those of us who have lived in Lymeland very long have learned that there is a parallel universe where mythology abounds and tyrants rule. This universe was exposed recently to those with open eyes and ears due to COVID. The resemblance to Lymeland was uncannily similar.
It simply doesn’t matter that those who are ill with Lyme/MSIDS suffer with ongoing symptoms, the system tells them they are either imagining it or making it all up. The parallel universe is ruled by ‘consensus‘ based medicine where a group decides what is true or not true and then teaches doctors their decision, demands complete obedience, which omits case studies, global research, and anything that defies the consensus narrative. Then insurance companies smugly hide behind these edicts given from above so patients are forced to pay out of pocket for any true help they receive.
Further, ‘the powers that be’ are actually behind the manipulation of these pathogens in a lab to make them stronger and more infectious. No wonder they don’t want to come clean. They have a lot to answer for. Remember the Tuskagee experiment? Author Dr. Colin Ross obtained FOIA documents for this unethical government experimentation and noted that:
“The Tuskeegee Syphilis Study was eventually shut down in 1972 because of the efforts of an investigative journalist. There is no evidence to suggest that the government or the medical profession had any intention of closing the study as of 1972.”
There’s many other experiments as well.
So denying it all is a perfect win.
For them.
In the video, Dr. Wodarg (pulmonologist and epidemiologist) speaks about how a false COVID ‘pandemic’ has been used for control. But COVID wasn’t his first rodeo. In the past he declared H1N1 a “false pandemic” and “one of the greatest medicine scandals of the century.” (Forbes, February 10, 2010). He is a modern day hero in my book.
https://lionessofjudah.substack.com/p/the-rise-of-the-digital-health-ecosystem?
How wearables, data centres and virtual “twins” are redefining Healthcare 4.0
Over the past few months, the phrase digital health ecosystem has crept into press releases, conference keynotes and policy documents. We are told that this new structure will make check-ups quicker, treatment cheaper and diagnostics sharper. Yet most people still wonder: What exactly is the digital health ecosystem, and why does every tech giant and government department seem to be racing to build it?
This article unpacks the concept, traces its technological building blocks and highlights the opportunities and threats hidden beneath the glossy marketing language.
Watch the presentation here:

Drive through almost any U.S. state and you will notice enormous, window-less warehouses springing up like mushrooms. These facilities are not retail hubs or logistics depots—they are data centers.
Inside, thousands of servers will store and process electronic medical files, insurance records, tax information and, increasingly, the live sensor data produced by wearable gadgets. Without this storage backbone the digital health ecosystem could not exist; vast computational power is the “prerequisite,” as one IEEE paper argues, for Healthcare 4.0 to function.
Early in 2025, a high-profile Silicon Valley partnership DOGE obtained access to 19 sensitive U.S. Health and Human Services databases. The cache included electronic health records, IRS files, Social Security numbers, addresses and bank details—an unprecedented consolidation of personal information.
Why does this matter to the emerging digital health ecosystem? Because predictive medicine, AI-driven drug discovery and remote patient management all feed on comprehensive, real-time data. The richer the dataset, the more marketable (and profitable) the algorithms built on top of it.
Robert F. Kennedy, in his role as Secretary of Health and Human Services, openly stated that he wants “a wearable on every American within four years.” His position is echoed by similar pledges in Europe and Asia.
Wearables—smart watches, rings, patches and even earpieces—act as the edge devices of the digital health ecosystem. They harvest heart rate, temperature, blood-oxygen, movement and sleep metrics, forwarding them through body-area and personal-area networks to those sprawling data centers.
Long before most people heard the term “generative AI,” government-funded programs such as Operation Stargate allocated more than $500 billion to AI-specific data centers. Oracle co-founder Larry Ellison boasted that the new architecture could design an mRNA vaccine “in 48 hours.”
These milestones reveal the deeper aim of the digital health ecosystem: a real-time feedback loop in which sensors feed data to the cloud, AI models simulate outcomes on “digital twins,” and automated factories print customized therapeutics on demand.
A 2018 article in IEEE “INTRODUCTION TO THE SPECIAL SECTION: CONVERGENCE OF AUTOMATION TECHNOLOGY BIOMEDICA ENGINEERING AND HEALTH INFORMATICS TOWARDS THE HEALTHCARE 4.0” spells out the ingredients of Healthcare 4.0…..
(See link for article)
_________________
**Comment**
If this article doesn’t scare the bejeebers out of you, you are asleep at the wheel.
Please read entire article in top link to educate yourself.
In short, if you believe Lyme/MSIDS is tightly controlled now, just wait for a digital health ecosystem. It will be impossible to get treatment anywhere as everything will be tyrannically monitored and controlled. The AMA and other sold out ‘professional’ organizations are already following ‘consensus’ based medicine – where decisions are made by consensus, rather than from reality, truth, or real science. Similar to how it has controlled COVID (banning effective treatments, bullying people into an experimental, never used before mRNA gene therapy, and persecuting doctors trying to save lives), it will be nearly impossible to even find an independent doctor willing to think for himself/herself.
A person in the comment section from the article stated something worth repeating here:
What stands out here is the reminder that these systems are not limited to the US, they form part of a much wider global agenda that is steadily being implemented across different countries.
This website has posted many articles on the unelected global elites and their evil plans: